Midgard Science

Labs / Protein production

ImunoTera

São Paulo, Brazil · en.imunotera.com.br

On your own

Free. Their own form.

Contact ImunoTera directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

ImunoTera develops therapeutic vaccines and other immunotherapies for cancer and infectious diseases. It is based at InovaHC in Brazil and was founded by scientists trained at USP.

Their website has a general contact form; we send your quote request through it.

What they offer

  • Act-Tera platform

    A recombinant-protein biotechnology platform designed with high therapeutic precision to combat various types of cancer.

  • Therapeutic vaccine development

    Develops therapeutic vaccines that can be applied through different immunological strategies.

  • DNA vaccine development

    Applies the platform as a DNA vaccine approach.

  • Protein vaccine development

    Applies the platform as a protein vaccine approach.

  • RNA vaccine development

    Applies the platform as an RNA vaccine approach.

  • Cell therapy development

    Applies the platform as a cell therapy approach.

What they work on

Modalities
Cell therapy, Recombinant protein, Vaccine
Therapeutic areas
cancer, infectious diseases
Serves
Brazil, global market
Founded
2016

Similar labs. 3C Therapeutics, Abnova, AbTherx, AGC Biologics

Found in a contract services directory. Listing built from en.imunotera.com.br. Work here? Claim this listing.

ImunoTera · Midgard Science